We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.36M -$2.75K -269 -0%
N
27
Nuveen
North Carolina
$6.1M -$286K -28,041 -4%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$5.5M +$1.24M +121,841 +25%
PHS
29
Pekin Hardy Strauss
Illinois
$5.21M +$1.3M +126,855 +29%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$5.12M +$3M +293,809 +110%
WP
31
Woodline Partners
California
$5.09M +$5.7M +557,799 New
NAM
32
Nexpoint Asset Management
Texas
$4.56M – – –
KBC Group
33
KBC Group
Belgium
$4.34M +$240K +23,483 +5%
Citigroup
34
Citigroup
New York
$4.02M +$2.5M +244,403 +125%
SEI Investments
35
SEI Investments
Pennsylvania
$3.6M +$700K +68,523 +21%
Deutsche Bank
36
Deutsche Bank
Germany
$3.55M -$1.44M -140,710 -27%
OCM
37
Orchard Capital Management
Illinois
$3.34M +$72.5K +7,100 +2%
CM
38
Caption Management
Oklahoma
$3.19M +$3.56M +349,110 New
Bank of America
39
Bank of America
North Carolina
$3.15M +$2.44M +238,708 +224%
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$3.08M +$201K +19,682 +6%
UBS Group
41
UBS Group
Switzerland
$2.92M +$726K +71,149 +29%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$2.73M -$337K -32,986 -10%
HWAM
43
Hennion & Walsh Asset Management
New Jersey
$2.7M -$726K -71,065 -19%
Morgan Stanley
44
Morgan Stanley
New York
$2.67M -$741K -72,570 -20%
AMH
45
Apollo Management Holdings
New York
$2.59M +$2.9M +283,859 New
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$2.43M +$749K +73,359 +38%
JG
47
Jefferies Group
New York
$2.37M +$2.65M +260,040 New
ORI
48
Oak Ridge Investments
Illinois
$1.98M -$221K -21,679 -9%
Allianz Asset Management
49
Allianz Asset Management
Germany
$1.97M +$2.2M +215,644 New
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.95M – – –
1
2
3 4 5

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.